Turning Point delighted to be part of newly funded national mental health clinical trials network
Today is International Clinical Trials Day, celebrating the role that clinical innovation plays in advancing health care- including in mental health and addiction.
A major investment in mental health clinical research was announced today, with $12 million support from the Federal Government’s Medical Research Future Fund (MRFF) towards establishing a national mental health clinical trials network.
The Mental Health Australia General Clinical Trial Network (MAGNET) will start as a five-year project, funded through the MRFF's Million Minds Mission. Led by Prof Michael Berk at Deakin University, the project brings together a team of 90 clinicians and researchers. Turning Point and Monash University are proud to be involved in this exciting venture, with Turning Point Executive Director Prof Dan Lubman and Deputy Clinical Director Dr Shalini Arunogiri both investigators on the project.
MAGNET includes researchers, consumer and carer groups, practitioner Colleges, research peak bodies, health systems and industry partners, insurers and Government agencies across all mental health conditions, from psychosis to eating disorders to addiction.
To learn more about MAGNET, read further here.